Mangoceuticals gets Nasdaq extension to regain $1 minimum bid price compliance by Feb. 1, 2027 - MGRX News | RalliesMangoceuticals gets Nasdaq extension to regain $1 minimum bid price compliance by Feb. 1, 2027
M
MGRX• Nasdaq gives Mangoceuticals more time to regain compliance
- Mangoceuticals received a 180-day Nasdaq extension to regain compliance with the $1 minimum bid price rule.
- The deadline to meet the requirement is Feb. 1, 2027, with compliance defined as at least 10 consecutive business days at $1 or higher.
- The company signaled it may use a reverse stock split to cure the deficiency within the extension period.
•
